Ranbaxy Lab reports consolidated net loss of Rs 2982.76 crore in Q4

24 Feb 2012 Evaluate

Ranbaxy Laboratories has reported results for fourth quarter and year ended December 31, 2011.

The company has reported net loss of Rs 27103.21 crore for the quarter and year ended December 31, 2011, against net profit of Rs 55.23 crore for the corresponding period last fiscal.  However, total income increased by 160.99% at Rs 4007.30 crore during the quarter under review from Rs 1535.40 crore in the year-ago period.

The company’s consolidated net loss was of Rs 2982.76 crore for the quarter and year ended December 31, 2011, against net loss of Rs 97.48 crore for the corresponding period last fiscal.  However total income increased by 77.95% at Rs 3955.47crore during the quarter under review from Rs 2222.82 crore in the year-ago period.

For the full year ended December 31, 2011, Ranbaxy has reported net loss of Rs 3052.04 crore against net profit of Rs 1148.72 crore in last year.  However total income increased by 33.22% at Rs 8036.38 crore from Rs 6032.43 crore in the year-ago period.

The company has reported consolidated net loss of Rs 2899.72 crore for the year ended December 31, 2011, against net profit of Rs 14967.51 crore in last fiscal.  However total income increased by 12.95% at Rs 10595.42 crore from Rs 9380.95 crore in the year-ago period.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×